About: Ruplizumab

An Entity of Type: monoclonal antibody, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia.

Property	Value
dbo:abstract	Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia. (en)
dbo:alternativeName	Antova (en)
dbo:casNumber	220651-94-5
dbo:fdaUniiCode	562JQF15GN
dbo:wikiPageID	9134294 (xsd:integer)
dbo:wikiPageLength	2197 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	977977298 (xsd:integer)
dbo:wikiPageWikiLink	dbc:Monoclonal_antibodies dbr:Systemic_lupus_erythematosus dbr:CD154 dbr:Lupus_nephritis dbr:Humanized_monoclonal_antibody dbr:Thrombocytopenia dbr:Rheumatic_disease dbr:Thromboembolism
dbp:atcPrefix	none (en)
dbp:casNumber	220651 (xsd:integer)
dbp:chemspiderid	none (en)
dbp:mabType	mab (en)
dbp:source	zu/o (en)
dbp:target	dbr:CD154
dbp:tradename	Antova (en)
dbp:type	mab (en)
dbp:unii	562 (xsd:integer)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	464384589 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Antineoplastic-drug-stub dbt:Drugbox dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Drugbankcite dbt:Fdacite dbt:Monoclonals_for_immune_system dbt:Immunosuppressants dbt:Monoclonal-antibody-stub
dcterms:subject	dbc:Monoclonal_antibodies
gold:hypernym	dbr:Antibody
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody yago:WikicatMonoclonalAntibodies yago:Abstraction100002137 yago:Antibody115027189 yago:Chemical114806838 yago:Compound114818238 yago:Macromolecule114944888 yago:Material114580897 yago:Matter100020827 yago:Molecule114682133 yago:MonoclonalAntibody115029781 yago:OrganicCompound114727670 yago:Part113809207 yago:PhysicalEntity100001930 yago:Protein114728724 yago:Relation100031921 dbo:Drug yago:Substance100019613 yago:Thing100002452 yago:Unit109465459
rdfs:comment	Ruplizumab (trade name Antova) is a humanized monoclonal antibody intended for the treatment of rheumatic diseases like systemic lupus erythematosus and lupus nephritis. A study showed that the drug was associated with life-threatening thromboembolisms, while another study only found thrombocytopenia. (en)
rdfs:label	Ruplizumab (en)
owl:sameAs	freebase:Ruplizumab yago-res:Ruplizumab wikidata:Ruplizumab dbpedia-vi:Ruplizumab https://global.dbpedia.org/id/4uHk5
prov:wasDerivedFrom	wikipedia-en:Ruplizumab?oldid=977977298&ns=0
foaf:isPrimaryTopicOf	wikipedia-en:Ruplizumab
is dbo:wikiPageWikiLink of	dbr:List_of_therapeutic_monoclonal_antibodies dbr:List_of_drugs:_Rf–Rz
is foaf:primaryTopic of	wikipedia-en:Ruplizumab